Source: United States & Canada – South China Morning PostThe European Union’s drug regulator on Monday approved use of the Covid-19 vaccine from US-based Novavax in people aged 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.Data from two large studies showed the vaccine has an efficacy of around 90 per cent, the European Medicines Agency (EMA) said, adding that there was currently limited data on its efficacy against some variants of concern, including Omicron.“After a thorough…Read More